Table 1.
Patient demographics according to SARS-CoV-2 status and proportions of samples positive for other respiratory pathogens in SARS-CoV-2 subsets.
| Characteristics and pathogensb | SARS-CoV-2 statusa |
|||
|---|---|---|---|---|
| Negative, n = 91 (39.2 %) |
Positive, n = 141 (60.8 %) |
|||
| Positive for other respiratory pathogenc | Negative for other respiratory pathogen | Positive for other respiratory pathogen | Negative for other respiratory pathogen | |
| No. Sample (%) | 13 (14.3) | 78 (85.7) | 7 (5) | 134 (95) |
| Age, mean (range) years | 59.1 (20–91) | 60.7 (18–101) | 66.1 (42–81) | 64.5 (29–89) |
| Male, No./total (%) | 7/13 (53.8) | 46/78 (58.9) | 6/7 (85.7) | 94/134 (70.1) |
| Site of specimen collection, No./total (%) | ||||
| ICU | 6/13 (46.2) | 50/78 (64.1) | 7/7 (100) | 122/134 (91.0) |
| Inpatient | 7/13 (53.8) | 28/78 (35.9) | 0/7 | 12/134 (9.0) |
| Influenza A | 2/91 (2.2) | 0/141 | ||
| Other Coronaviridae | 1/91 (1.1) | 0/141 | ||
| Metapneumovirus | 3/91 (3.3) | 5/141 (3.5) | ||
| Parainfluenza 1-4 | 0/91 | 1/141 (0.7) | ||
| Rhinovirus/Enterovirus | 7/91 (7.7) | 0/141 | ||
| RSV | 1/91 (1.1) | 0/141 | ||
| Mycoplasma pneumoniae | 0/91 | 1/141 (0.7) | ||
a
The 232 patients were tested for each respiratory pathogen. Differences in proportion were evaluated with Fisher tests (significance, P < 0.05). Analyses were performed using Prism v.7.
b
Influenza B, Adenovirus and C. pneumoniae were never detected.
c
One patient was positive for Metapneumovirus and Rhinovirus/Enterovirus.